What's Happening?
CoapTech, a medical technology company specializing in ultrasound-guided solutions, has appointed Brad Kreger as its new CEO. Kreger succeeds Howard Carolan, who will remain as an advisor. Kreger brings
extensive experience from his previous roles at Velo3D and Fluidigm Corporation. The transition aims to accelerate CoapTech's growth and expand access to its percutaneous ultrasound gastrostomy technology, which has recently received FDA clearance for pediatric use.
Why It's Important?
The leadership change at CoapTech is significant for the company's strategic direction and growth in the medical device industry. Kreger's expertise in scaling organizations and his background in medical device manufacturing are expected to drive CoapTech's expansion and adoption of its innovative gastrostomy technology. This transition could enhance patient outcomes and broaden the company's impact in healthcare settings, positioning CoapTech as a leader in ultrasound-guided medical solutions.
